The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Ethnic Differences in Cardiovascular Drug Response: Potential Contribution of Pharmacogenetics
Open accessAbstract
I n the early 1980s, clinical differences in response to the blood pressure (BP)-lowering effects of -blockers and, to a lesser extent, diuretics were noted between ethnic groups.The most convincing evidence at that time came from a Veterans Affairs (VA) Cooperative Trial, 1 which, along with other smaller studies, suggested that whites (those of European ancestry) had a better antihypertensive response to -blockers than blacks (those of African ancestry), whereas blacks had a slight better response to diuretics than whites.Shortly after the first angiotensin-converting enzyme (ACE) inhibitor was approved in the mid-1980s, it was also recognized that whites responded more favorably to ACE inhibitors than did blacks.Over time, these differences in response became well accepted, such that ethnicity began to be used in helping to guide selection of antihypertensive drug therapy.2,3 Although the ethnic differences in response between -blockers and ACE inhibitors in hypertension are perhaps the mostly widely recognized examples of ethnic differences in response to cardiovascular drugs, there are others.Pharmacogenetics is a field that seeks to unravel the genetic underpinnings of variable drug responses.4 Given the recognized ethnic differences in drug responses and the fact that many genetic polymorphisms differ in frequency on the basis of ethnicity/ancestry, questions about whether pharmacogenetics may also lead to an understanding of the ethnic differences in drug response are not surprising.The present review will summarize the most widely recognized examples of cardiovascular drugs with differential response by ethnicity and the evidence that pharmacogenetics data may aid in our understanding of these differences.Given that there are many examples in the literature of genetic associations that are not replicated, the pharmacogenetic examples discussed herein will come from those for which there is some evidence of replication or for which there have been multiple negative findings.In light of the socially charged issues that surround race and genetics, we will typically refer to groups either as ethnic groups (meaning groups who may have similar ancestral origins and who share certain social or cultural practices) or will refer to continental ancestry, referring to the 3 major continental populations from which the human population mainly derives (namely, European, African, and Asian ancestry).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Shekelle, P. G., Rich, M. W., Morton, S. C., Atkinson, C. S. W., Tu, W., Maglione, M., Rhodes, S., Barrett, M., Fonarow, G. C., Greenberg, B., et al. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00262-6 · Cited by 492
Takahashi, H., Wilkinson, G. R., Nutescu, E. A., Morita, T., Ritchie, M. D., Scordo, M. G., Pengo, V., Barban, M., Padrini, R., Ieiri, I., et al. (2006) · Pharmacogenetics and Genomics · doi:10.1097/01.fpc.0000184955.08453.a8 · Cited by 376
Domanski, M. J., Krause-Steinrauf, H., Massie, B. M., Deedwania, P., Follmann, D., Kovar, D., Murray, D., Oren, R., Rosenberg, Y., Young, J., et al. (2003) · Journal of Cardiac Failure · doi:10.1054/s1071-9164(03)00133-7 · Cited by 176
Cited by
Carnethon, M. R., Pu, J., Howard, G., Albert, M. A., Anderson, C. A. M., Bertoni, A. G., Mujahid, M. S., Palaniappan, L., Taylor, H. A., Willis, M., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000534 · Cited by 1,147
Pharmacogenomics of GPCR Drug Targets
Hauser, A. S., Chavali, S., Masuho, I., Jahn, L. J., Martemyanov, K. A., Gloriam, D. E., & Babu, M. M. (2018) · Cell · doi:10.1016/j.cell.2017.11.033 · Cited by 616
Brozovich, F. V., Nicholson, C. J., Degen, C. V., Gao, Y. Z., Aggarwal, M., & Morgan, K. G. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.010652 · Cited by 542
Genome-wide patterns of population structure and admixture in West Africans and African Americans
Bryc, K., Auton, A., Nelson, M. R., Oksenberg, J. R., Hauser, S. L., Williams, S., Froment, A., Bodo, J.-M., Wambebe, C., Tishkoff, S. A., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909559107 · Cited by 455
Population-based high-throughput toxicity screen of human iPSC-derived cardiomyocytes and neurons
Huang, C. Y., Nicholson, M. W., Wang, J. Y., Ting, C. Y., Tsai, M. H., Cheng, Y. C., Liu, C. L., Chan, D. Z. H., Lee, Y. C., Hsu, C. C., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110643 · Cited by 36
Metadata
- Authors
- Johnson, J. A.
- Venue
- Circulation
- Published
- 2008-09-23
- Volume
- 118
- Issue
- 13
- Pages
- 1383-1393
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2133132829
- Cited by
- 212
- References
- 3
- FWCI
- 5.79
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Ethnic Differences in Cardiovascular Drug Response: Potential Contribution of Pharmacogenetics. https://app.cochat.ai/papers/10.1161/circulationaha.107.704023
- The paper
- Johnson, J. A. (2008). Ethnic Differences in Cardiovascular Drug Response: Potential Contribution of Pharmacogenetics. Circulation. https://doi.org/10.1161/circulationaha.107.704023
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.